Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|7|1|13-20

ISSN: 2045-7634

Source: Cancer Medicine, Vol.7, Iss.1, 2018-01, pp. : 13-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content